ALSPW Stock Overview
Engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Spineway SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.085 |
| 52 Week High | €30.00 |
| 52 Week Low | €0.073 |
| Beta | 1.47 |
| 1 Month Change | -3.41% |
| 3 Month Change | -74.09% |
| 1 Year Change | -99.01% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Not Many Are Piling Into Spineway SA (EPA:ALSPW) Stock Yet As It Plummets 32%
Mar 19
Market Might Still Lack Some Conviction On Spineway SA (EPA:ALSPW) Even After 162% Share Price Boost
Jan 31Is Spineway (EPA:ALSPW) Using Debt Sensibly?
Apr 12Spineway Société Anonyme (EPA:ALSPW) Has Debt But No Earnings; Should You Worry?
Dec 27Is Spineway Société Anonyme (EPA:ALSPW) Using Too Much Debt?
May 14Spineway Société Anonyme's (EPA:ALSPW) Shift From Loss To Profit
Mar 22Spineway Société Anonyme (EPA:ALSPW) Has Debt But No Earnings; Should You Worry?
Jan 28
Shareholder Returns
| ALSPW | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 1.9% | 0.003% | -1.7% |
| 1Y | -99.0% | 23.6% | -4.8% |
Return vs Industry: ALSPW underperformed the French Medical Equipment industry which returned 23.6% over the past year.
Return vs Market: ALSPW underperformed the French Market which returned -4.8% over the past year.
Price Volatility
| ALSPW volatility | |
|---|---|
| ALSPW Average Weekly Movement | 28.4% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALSPW's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALSPW's weekly volatility has decreased from 61% to 28% over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 48 | Stephane Le Roux | www.spineway.com |
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; posterior osteosynthesis systems; kili, an anterior lumbar interbody fusion cage; twin peaks plif posterior lumbar interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides neve, a biomaterial bone substitute for bone regeneration; and cervical and lumbar prosthesis elastic spine pads.
Spineway SA Fundamentals Summary
| ALSPW fundamental statistics | |
|---|---|
| Market cap | €70.80k |
| Earnings (TTM) | -€8.00m |
| Revenue (TTM) | €11.99m |
0.0x
P/S Ratio0.0x
P/E RatioIs ALSPW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALSPW income statement (TTM) | |
|---|---|
| Revenue | €11.99m |
| Cost of Revenue | €9.32m |
| Gross Profit | €2.67m |
| Other Expenses | €10.67m |
| Earnings | -€8.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -9.60 |
| Gross Margin | 22.26% |
| Net Profit Margin | -66.71% |
| Debt/Equity Ratio | 8.8% |
How did ALSPW perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:01 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Spineway SA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arnaud Guérin | Portzamparc BNP Paribas |
| Mohamed Kaabouni | Portzamparc BNP Paribas |